A carregar...

Effect of P-glycoprotein on flavopiridol sensitivity

Flavopiridol is the first potent inhibitor of cyclin-dependent kinases (CDKs) to enter clinical trials. Little is known about mechanisms of resistance to this agent. In order to determine whether P-glycoprotein (Pgp) might play a role in flavopiridol resistance, we examined flavopiridol sensitivity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Boerner, S A, Tourne, M E, Kaufmann, S H, Bible, K C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2001
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363628/
https://ncbi.nlm.nih.gov/pubmed/11355953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1688
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!